IN SEARCH OF A SMALL MOLECULE CURE FOR HIV-AIDS: DEVELOPMENT OF DUAL-ACTION AGENTS CAPABLE OF SIMULTANEOUSLY ACTIVATING HIV-1 LATENCY AND PREVENTING NEW INFECTION